☆ 4.8 Editorial Material

Aggregates of TDP-43 protein spiral into view

NATURE (2022)

Journal

NATURE

Volume 601, Issue 7891, Pages 29-30

Publisher

NATURE PORTFOLIO

DOI: 10.1038/d41586-021-03605-0

Keywords

-

Categories

Multidisciplinary Sciences

Ask authors/readers for more resources

Protocol

Community support

Reagent

Community support

Authors

I am an author on this paper

Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.8

Not enough ratings

Secondary Ratings

Novelty

-

Significance

-

Scientific rigor

-

Rate this paper

Recommended

Correction Clinical Neurology

Antibody against TDP-43 phosphorylated at serine 369 suggests conformational differences of TDP-43 aggregates among FTLD-TDP subtypes (vol 140, pg 645, 2020)

Manuela Neumann, Petra Frick, Francesca Paron, Jonas Kosten, Emanuele Buratti, Ian R. Mackenzie

Summary: The originally planned amino acid residues 368-379 for antibody production in TDP-43 protein sequence were incorrectly assigned to 362-373 by the contracted company, resulting in the synthesis and use of a peptide with a phosphorylated serin at 369 instead of 375.

ACTA NEUROPATHOLOGICA (2021)

Add to Collection

Article Biochemistry & Molecular Biology

Disease-linked TDP-43 hyperphosphorylation suppresses TDP-43 condensation and aggregation

Lara A. Gruijs da Silva, Francesca Simonetti, Saskia Hutten, Henrick Riemenschneider, Erin L. Sternburg, Lisa M. Pietrek, Jakob Gebel, Volker Doetsch, Dieter Edbauer, Gerhard Hummer, Lukas S. Stelzl, Dorothee Dormann

Summary: This translated article investigates the regulatory role of post-translational modifications (PTMs) on protein phase separation and aggregation. The study finds that hyperphosphorylation of TDP-43 protein has a protective effect, reducing aggregation and making the condensates more liquid-like and dynamic.

EMBO JOURNAL (2022)

Add to Collection

Article Cell Biology

Degradation of neurodegenerative disease-associated TDP-43 aggregates and oligomers via a proteolysis-targeting chimera

Yu-Ling Tseng, Po-Chao Lu, Chi-Chang Lee, Ruei-Yu He, Yung-An Huang, Yin-Chen Tseng, Ting-Jen Rachel Cheng, Joseph Jen-Tse Huang, Jim-Min Fang

Summary: A series of proteolysis targeting chimeras (PROTACs) were designed to degrade C-terminal TAR DNA-binding protein 43 (C-TDP-43) in amyotrophic lateral sclerosis (ALS) cells. One of the PROTACs (PROTAC 2) was found to reduce the aggregates and oligomers of C-TDP-43, thereby decreasing their neurotoxicity.

JOURNAL OF BIOMEDICAL SCIENCE (2023)

Add to Collection

Article Clinical Neurology

Distinct brain-derived TDP-43 strains from FTLD-TDP subtypes induce diverse morphological TDP-43 aggregates and spreading patterns in vitro and in vivo

Silvia Porta, Yan Xu, Tagan Lehr, Bin Zhang, Emily Meymand, Modupe Olufemi, Anna Stieber, Edward B. Lee, John Q. Trojanowski, Virginia M. -Y. Lee

Summary: This study demonstrates the presence of distinct TDP-43 strains in the brains of different FTLD-TDP subtypes with specific seeding and spreading properties in experimental animal models.

NEUROPATHOLOGY AND APPLIED NEUROBIOLOGY (2021)

Add to Collection

Article Chemistry, Medicinal

Strategies in the design and development of (TAR) DNA-binding protein 43 (TDP-43) binding ligands

Praveen P. N. Rao, Arash Shakeri, Yusheng Zhao, Frederic Calon

Summary: TDP-43 is a protein involved in various physiological processes and diseases, known collectively as TDP-43 proteinopathies. Recent research has deepened our understanding of its structure and function, with solved structures providing insights for designing ligands to study, diagnose, and treat TDP-43 proteinopathies.

EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2021)

Add to Collection

Article Biochemistry & Molecular Biology

Novel insights into the structural changes induced by disease-associated mutations in TDP-43: a computational approach

Abhibhav Sharma, Pinki Dey

Summary: The aggregation of TDP-43 is strongly associated with fatal neurodegenerative diseases, and mutations may accelerate this process. This study investigated the effects of three disease-related mutations on the stability of TDP-43 protein using molecular dynamic simulation and machine learning models. The findings provide insights into potential therapeutic strategies.

JOURNAL OF BIOMOLECULAR STRUCTURE & DYNAMICS (2023)

Add to Collection

Article Neurosciences

The Role of TDP-43 in Neurodegenerative Disease

Yan-Zhe Liao, Jing Ma, Jie-Zhi Dou

Summary: In recent years, it has been discovered that more and more neurodegenerative diseases exhibit abnormal expression of the TDP-43 protein, including depletion of TDP-43 in the nucleus and accumulation of TDP-43 in the cytoplasm. This TDP-43 proteinopathy suggests the important role of TDP-43 in the pathogenesis of these diseases, and further research is needed to understand the complex pathophysiological mechanisms of TDP-43 in neurodegenerative diseases.

MOLECULAR NEUROBIOLOGY (2022)

Add to Collection

Article Multidisciplinary Sciences

Insights into the aggregation mechanism of RNA recognition motif domains in TDP-43: a theoretical exploration

Wei Liu, Chaoqun Li, Jiankai Shan, Yan Wang, Guangju Chen

Summary: This study examined the oligomer models of the RRM domains of TDP-43 through molecular dynamics simulations and protein-protein docking, revealing that interactions between RRM1 domains and parallel beta-sheet layers play crucial roles in the formation of dimers. The allosteric communication between alpha 1/alpha 2 helices of the RRM1 domains helps maintain binding affinities and interactions in larger oligomer models, ultimately leading to the formation of large aggregation models with repeated, helical, and rope-like structures in TDP-43.

ROYAL SOCIETY OPEN SCIENCE (2021)

Add to Collection

Review Pharmacology & Pharmacy

TDP-43 protein interactome informs about perturbed canonical pathways and may help develop personalized medicine approaches for patients with TDP-43 pathology

Benjamin R. Helmold, Kate E. Pauss, P. Hande Ozdinler

Summary: TDP-43 pathology, a common proteinopathy in neurodegenerative diseases, is believed to be caused in part by the protein-protein interactions of TDP-43 with other proteins. By investigating the binding of TDP-43 with proteins in different domains, key cellular events and compounds that can modulate canonical pathways have been identified. This suggests the feasibility of personalized medicine approaches targeting perturbed cellular mechanisms.

DRUG DISCOVERY TODAY (2023)

Add to Collection

Article Biochemistry & Molecular Biology

Nuclear Expression of TDP-43 Is Linked with Morphology and Ubiquitylation of Cytoplasmic Aggregates in Amyotrophic Lateral Sclerosis

Hiroyuki Yabata, Yuichi Riku, Hiroaki Miyahara, Akio Akagi, Jun Sone, Makoto Urushitani, Mari Yoshida, Yasushi Iwasaki

Summary: The study aimed to evaluate the relationship between the expression level of nuclear TDP-43 and the pathological properties of cytoplasmic aggregates in ALS cases. The results showed that the maturation of cytoplasmic TDP-43 inclusions correlates with the depletion of nuclear TDP-43 in each affected neuron. This suggests that an imbalance between nuclear and cytoplasmic TDP-43 may be an essential pathway to TDP-43 pathology.

INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2023)

Add to Collection

Article Biochemistry & Molecular Biology

Aggregation-prone TDP-43 sequesters and drives pathological transitions of free nuclear TDP-43

Sean S. Keating, Adekunle T. Bademosi, Rebecca San Gil, Adam K. Walker

Summary: Aggregation of TDP-43 is the hallmark of neurodegenerative diseases, involving depletion, mislocalisation, and post-translational modification of normal nuclear TDP-43. Oxidative stress triggers liquid-liquid phase separation of TDP-43, while RNA-binding deficiency and acetylation mimicry lead to sequestration of normal nuclear TDP-43 into dynamic anisosomes. Nuclear or cytoplasmic aggregation-prone TDP-43 mutants form phosphorylated inclusions that immobilize and insolubilize endogenous TDP-43, indicating pathological transition. Overall, these findings highlight the importance of RNA-binding deficiency and post-translational modifications in driving TDP-43 aggregation and dysfunction in neurodegenerative diseases.

CELLULAR AND MOLECULAR LIFE SCIENCES (2023)

Add to Collection

Article Biochemistry & Molecular Biology

Hsp90 and its co-chaperone Sti1 control TDP-43 misfolding and toxicity

Lilian Tsai-Wei Lin, Abdul Razzaq, Sonja E. Di Gregorio, Soojie Hong, Brendan Charles, Marilene H. Lopes, Flavio Beraldo, Vania F. Prado, Marco A. M. Prado, Martin L. Duennwald

Summary: Protein misfolding is a key characteristic of most neurodegenerative diseases. Molecular chaperones such as Hsp90 and its co-chaperone Sti1 play a role in modulating the toxicity associated with TDP-43 misfolding and inclusion formation. Impaired Hsp90 function sensitizes cells to TDP-43 toxicity, while Sti1 specifically interacts with TDP-43 and strongly modulates its toxicity in a dose-dependent manner.

FASEB JOURNAL (2021)

Add to Collection

Article Clinical Neurology

Truncated TDP-43 proteoforms diagnostic of frontotemporal dementia with TDP-43 pathology

Lauren M. Forgrave, Kyung-Mee Moon, Jordan E. Hamden, Yun Li, Phoebe Lu, Leonard J. Foster, Ian R. A. Mackenzie, Mari L. DeMarco

Summary: Biomarkers of TDP-43 pathology are needed to differentiate FTLD-TDP from related disorders. Using high-resolution mass spectrometry, we identified truncated TDP-43 as a potential biomarker with high diagnostic accuracy for FTLD-TDP.

ALZHEIMERS & DEMENTIA (2023)

Add to Collection

Article Biochemistry & Molecular Biology

O-GlcNAcylation of TDP-43 suppresses proteinopathies and promotes TDP-43's mRNA splicing activity

Meng-Jie Zhao, Xiao Yao, Ping Wei, Chen Zhao, Meng Cheng, Dong Zhang, Wen Xue, Wen-Tian He, Weili Xue, Xinxin Zuo, Lei-Lei Jiang, Zhiyuan Luo, Jiaqi Song, Wen-Jie Shu, Han-Ye Yuan, Yi Liang, Hui Sun, Yan Zhou, Yu Zhou, Ling Zheng, Hong-Yu Hu, Jiwu Wang, Hai-Ning Du

Summary: Research has shown that O-GlcNAc transferase OGT-mediated O-GlcNAcylation of TDP-43 can suppress ALS-related proteinopathies and enhance TDP-43's splicing function. This study further demonstrates the importance of TDP-43 O-GlcNAcylation in maintaining neuronal health and function.

EMBO REPORTS (2021)

Add to Collection

Review Clinical Neurology

Frontotemporal lobar degeneration with TAR DNA-binding protein 43 (TDP-43): its journey of more than 100 years

Arenn F. Carlos, Keith A. Josephs

Summary: This paper reviews how FTLD-TDP was established and defined clinically and neuropathologically throughout the past century.

JOURNAL OF NEUROLOGY (2022)

Add to Collection

Article Hematology

Heterozygous variants of CLPB are a cause of severe congenital neutropenia

Julia T. Warren, Ryan R. Cupo, Peeradol Wattanasirakul, David H. Spencer, Adam E. Locke, Vahagn Makaryan, Audrey Anna Bolyard, Merideth L. Kelley, Natalie L. Kingston, James Shorter, Christine Bellanne-Chantelot, Jean Donadieu, David C. Dale, Daniel C. Link

Summary: Genetic analysis of patients with congenital neutropenia revealed an association between CLPB variants and the disease. CLPB variants obstruct the differentiation of granulocytes and increase apoptosis, contributing to the development of neutropenia. This study provides new insights into the diagnosis and treatment of congenital neutropenia.

BLOOD (2022)

Add to Collection

Review Biochemistry & Molecular Biology

Nuclear-Import Receptors Counter Deleterious Phase Transitions in Neurodegenerative Disease

Hana M. Odeh, Charlotte M. Fare, James Shorter

Summary: The article discusses the role of nuclear import receptors (NIRs) in nuclear transport and their ability to chaperone and disaggregate NLS-bearing clients in the cytoplasm. It highlights the finding that NIRs can also antagonize aberrant interactions and toxicity of proteins associated with neurodegenerative diseases. Additionally, NIR family members are shown to prevent and reverse liquid-liquid phase separation of specific clients independent of nuclear localization signals (NLS). Strategies to enhance NIR activity or expression for the treatment of neurodegenerative disorders are also discussed.

JOURNAL OF MOLECULAR BIOLOGY (2022)

Add to Collection

Article Biochemistry & Molecular Biology

Poly(ADP-ribose) drives condensation of FUS via a transient interaction

Kevin Rhine, Morgan Dasovich, Joseph Yoniles, Mohsen Badiee, Sophie Skanchy, Laura R. Ganser, Yingda Ge, Charlotte M. Fare, James Shorter, Anthony K. L. Leung, Sua Myong

Summary: This study demonstrates how Poly(ADP-ribose) (PAR) triggers condensation of FUS at a low concentration, and reveals a different mode of interaction between PAR and FUS compared to RNA.

MOLECULAR CELL (2022)

Add to Collection

Article Cell Biology

Unique structural features govern the activity of a human mitochondrial AAA plus disaggregase, Skd3

Ryan R. Cupo, Alexandrea N. Rizo, Gabriel A. Braun, Eric Tse, Edward Chuang, Kushol Gupta, Daniel R. Southworth, James Shorter

Summary: The high-resolution structure of Skd3-substrate complex is reported, revealing the mechanism of Skd3 protein disaggregation and its association with disease inheritance patterns.

CELL REPORTS (2022)

Add to Collection

Article Biochemistry & Molecular Biology

A minimal construct of nuclear-import receptor Karyopherin-β2 defines the regions critical for chaperone and disaggregation activity

Charlotte M. Fare, Kevin Rhine, Andrew Lam, Sua Myong, James Shorter

Summary: KapP2 is a nuclear-import receptor that transports various cytoplasmic cargo, including disease-linked RNA-binding proteins, to the nucleus. These RNA-binding proteins with prion-like domains are associated with degenerative disorders. KapP2 can prevent and reverse aberrant phase transitions of these proteins, providing cytoprotection. The molecular determinants of KapP2's activities are poorly understood, but truncations lacking cargo-binding repeats show reduced activity. HEAT repeats 8 to 20 of KapP2 recapitulate its activity, making them a potential therapeutic target for related disorders.

JOURNAL OF BIOLOGICAL CHEMISTRY (2023)

Add to Collection

Article Biochemistry & Molecular Biology

Phase Separation in Biology and Disease; Current Perspectives and Open Questions

Steven Boeynaems, Shasha Chong, Jorg Gsponer, Liam Holt, Dragomir Milovanovic, Diana M. Mitrea, Oliver Mueller-Cajar, Bede Portz, John F. Reilly, Christopher D. Reinkemeier, Benjamin R. Sabari, Serena Sanulli, James Shorter, Emily Sontag, Lucia Strader, Jeanne Stachowiak, Stephanie C. Weber, Michael White, Huaiying Zhang, Markus Zweckstetter, Shana Elbaum-Garfinkle, Richard Kriwacki

Summary: Over the past 15 years, a new scientific field called biomolecular condensates has emerged, focusing on the study of membraneless bodies in cells and their roles in biological processes and disease. These condensates are formed through phase separation and have been found to play crucial roles in various cellular functions and disease pathways. Through a week-long workshop, scientists discussed the key questions and insights in this field, including the applications of condensates in synthetic biology and potential therapeutic targeting.

JOURNAL OF MOLECULAR BIOLOGY (2023)

Add to Collection

Article Neurosciences

Nuclear import receptors are recruited by FG-nucleoporins to rescue hallmarks of TDP-43 proteinopathy

Bilal Khalil, Deepak Chhangani, Melissa C. Wren, Courtney L. Smith, Jannifer H. Lee, Xingli Li, Christian Puttinger, Chih-Wei Tsai, Gael Fortin, Dmytro Morderer, Junli Gao, Feilin Liu, Chun Kim Lim, Jingjiao Chen, Ching-Chieh Chou, Cara L. Croft, Amanda M. Gleixner, Christopher J. Donnelly, Todd E. Golde, Leonard Petrucelli, Bjorn Oskarsson, Dennis W. Dickson, Ke Zhang, James Shorter, Shige H. Yoshimura, Sami J. Barmada, Diego E. Rincon-Limas, Wilfried Rossoll

Summary: The study found that members of the nuclear import receptor protein family can reduce the formation of pathological TDP-43 aggregates. Using KPNB1 as a model, it was discovered that its activity depends on the prion-like C-terminal region of TDP-43, mediating co-aggregation with nucleoporins such as Nup62. KPNB1 acts as a molecular chaperone in these co-aggregates, reversing the aberrant phase transition of Nup62 and TDP-43.

MOLECULAR NEURODEGENERATION (2022)

Add to Collection

Article Clinical Neurology

C-terminal frameshift variant of TDP-43 with pronounced aggregation-propensity causes rimmed vacuole myopathy but not ALS/FTD

Pedro Ervilha Pereira, Nika Schuermans, Antoon Meylemans, Pontus LeBlanc, Lauren Versluys, Katie E. E. Copley, Jack D. D. Rubien, Christopher Altheimer, Myra Peetermans, Elke Debackere, Olivier Vanakker, Sandra Janssens, Jonathan Baets, Kristof Verhoeven, Martin Lammens, Sofie Symoens, Boel De Paepe, Sami J. J. Barmada, James Shorter, Jan L. L. De Bleecker, Elke Bogaert, Bart Dermaut

Summary: This study identified a TDP-43(p.Trp385IlefsTer10) mutation in a family, which led to the presence of TDP-43-positive inclusions in muscle cells and the development of autosomal dominant rimmed vacuole myopathy. The mutation was found to increase the aggregation propensity of TDP-43, but it was not associated with ALS and FTD.

ACTA NEUROPATHOLOGICA (2023)

Add to Collection

Review Chemistry, Multidisciplinary

Regulation of Biomolecular Condensates by Poly(ADP-ribose)

Kevin Rhine, Hana M. Odeh, James Shorter, Sua Myong

Summary: Biomolecular condensates are reversible compartments formed through phase separation, which can be nucleated by post-translational modifications like ADP-ribosylation. Poly(ADP-ribose) (PAR) chains, transient modifications with short turnover rates, play a crucial role in granule formation and are associated with neurodegenerative diseases. This review explores the synthesis, regulation, structure, chemistry, and protein interactions of PAR, as well as recent progress in understanding its role in phase separation and potential as a target for neurodegenerative disease treatments.

CHEMICAL REVIEWS (2023)

Add to Collection

Review Genetics & Heredity

Repetitive elements in aging and neurodegeneration

Katie E. Copley, James Shorter

Summary: Repetitive elements (REs), including transposable elements (TEs) and satellites, play a significant role in aging and neurodegenerative disorders. Changes in RE expression, retrotransposition, and chromatin microenvironment can affect lifespan, neurodegeneration, memory, and movement. REs can cause these effects through DNA damage, protein sequestration, insertional mutagenesis, and inflammation. The study focuses on different TE families and their interaction with factors like TDP-43 and the siRNA and piRNA systems.

TRENDS IN GENETICS (2023)

Add to Collection

Editorial Material Chemistry, Multidisciplinary

Introduction: Phase Separation

Sua Myong, James Shorter

CHEMICAL REVIEWS (2023)

Add to Collection

Article Biochemistry & Molecular Biology

Tuning Hsp104 specificity to selectively detoxify a-synuclein

Korrie L. Mack, Hanna Kim, Edward M. Barbieri, Jiabei Lin, Sylvanne Braganza, Meredith E. Jackrel, Jamie E. Denizio, Xiaohui Yan, Edward Chuang, Amber Tariq, Ryan R. Cupo, Laura M. Castellano, Kim A. Caldwell, Guy A. Caldwell, James Shorter

Summary: By engineering substrate-specific variants of the Hsp104 protein, researchers have developed a way to mitigate the toxic misfolding of proteins associated with fatal neurodegenerative disorders. These variants selectively suppress the toxicity of α-synuclein while not affecting the toxicity of TDP-43 or FUS. The specific variants reduce dopamine neuron degeneration more effectively in a Parkinson's disease model compared to non-specific variants.

MOLECULAR CELL (2023)

Add to Collection

Article Biology

Transcriptome-wide RNA binding analysis of C9orf72 poly(PR) dipeptides

Rubika Balendra, Igor Ruiz de los Mozos, Hana M. Odeh, Idoia Glaria, Carmelo Milioto, Katherine M. Wilson, Agnieszka M. Ule, Martina Hallegger, Laura Masino, Stephen Martin, Rickie Patani, James Shorter, Jernej Ule, Adrian M. Isaacs

Summary: An intronic GGGGCC repeat expansion in C9orf72 is a common genetic cause of amyotrophic lateral sclerosis and frontotemporal dementia. Poly(GA), poly(GR), and poly(PR) dipeptide repeat proteins generated from the repeats are implicated in neurodegeneration. In this study, we performed CLIP analysis and found that poly(PR) binds to nearly 600 RNAs, with enrichment of the sequence GAAGA at the binding sites. In vitro experiments showed that poly(GAAGA) RNA has a higher affinity for poly(PR) and induces its phase separation into condensates.

LIFE SCIENCE ALLIANCE (2023)

Add to Collection

Correction Multidisciplinary Sciences

A yeast functional screen predicts new candidate ALS disease genes (vol 108, pg 20881, 2011)

Julien Couthouis, Michael P. Hart, James Shorter, Mariely DeJesus-Hernandez, Renske Erion, Rachel Oristano, Annie X. Liu, Daniel Ramos, Niti Jethava, Divya Hosangadi, James Epstein, Ashley Chiang, Zamia Diaz, Tadashi Nakaya, Fadia Ibrahim, Hyung-Jun Kim, Jennifer A. Solski, Kelly L. Williams, Jelena Mojsilovic-Petrovic, Caroline Ingre, Kevin Boylan, Neill R. Graff-Radford, Dennis W. Dickson, Dana Clay-Falcone, Lauren Elman, Leo McCluskey, Robert Greene, Robert G. Kalb, Virginia M. -Y. Lee, John Q. Trojanowski, Albert Ludolph, Wim Robberecht, Peter M. Andersen, Garth A. Nicholson, Ian P. Blair, Oliver D. King, Nancy M. Bonini, Vivianna Van Deerlin, Rosa Rademakers, Zissimos Mourelatos, Aaron D. Gitler

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2022)

Add to Collection

Article Chemistry, Multidisciplinary

Advanced Molecular Tweezers with Lipid Anchors against SARS-CoV-2 and Other Respiratory Viruses

Tatjana Weil, Abbna Kirupakaran, My-Hue Le, Philipp Rebmann, Joel Mieres-Perez, Leila Issmail, Carina Conzelmann, Janis A. Mueller, Lena Rauch, Andrea Gilg, Lukas Wettstein, Ruediger Gross, Clarissa Read, Tim Bergner, Sandra Axberg Palsson, Nadja Uhlig, Valentina Eberlein, Heike Woell, Frank-Gerrit Klaerner, Steffen Stenger, Beate M. Kuemmerer, Hendrik Streeck, Giorgio Fois, Manfred Frick, Peter Braubach, Anna-Lena Spetz, Thomas Grunwald, James Shorter, Elsa Sanchez-Garcia, Thomas Schrader, Jan Muench

Summary: This study discovered that a class of drugs called molecular tweezers can disrupt the envelope of SARS-CoV-2 and render the virus non-infectious. By modifying the molecular structure, researchers identified a series of advanced molecular tweezers that showed enhanced ability to destroy lipid bilayers and suppress SARS-CoV-2 infection. These potentiated tweezers demonstrated activity against various viruses, including respiratory syncytial virus, influenza, and measles viruses, in addition to SARS-CoV-2. The inhibitory effects of the advanced tweezers against respiratory syncytial virus and SARS-CoV-2 were also validated in mice. Therefore, these broad-spectrum antiviral agents have great potential for clinical development in combating highly pathogenic viruses.

JACS AU (2022)

Add to Collection

No Data Available

© Peeref 2019-2024. All rights reserved.